December 2014; 1 (4) Views & ReviewsOpen Access
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis
Ana C. Londoño, Carlos A. Mora
First published November 20, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000045
Ana C. Londoño
From the Neurological Institute of Colombia–INDEC and Link Diagnostico Digital (A.C.L.), Medellín, Colombia; and Department of Neurology (C.A.M.), Georgetown Multiple Sclerosis Center, MedStar Georgetown University Hospital, Washington, DC.
MDCarlos A. Mora
From the Neurological Institute of Colombia–INDEC and Link Diagnostico Digital (A.C.L.), Medellín, Colombia; and Department of Neurology (C.A.M.), Georgetown Multiple Sclerosis Center, MedStar Georgetown University Hospital, Washington, DC.
MDNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis
Ana C. Londoño, Carlos A. Mora
Neurol Neuroimmunol Neuroinflamm Dec 2014, 1 (4) e45; DOI: 10.1212/NXI.0000000000000045
Citation Manager Formats
Make Comment
See Comments

Article Figures & Data
Tables
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?Robert Zivadinov et al.Neurology, June 04, 2007 -
Views and Reviews
The contribution of MRI in assessing cognitive impairment in multiple sclerosisM. Filippi, M.A. Rocca, R.H.B. Benedict et al.Neurology, December 06, 2010 -
Article
MS, MRI, and the 2010 McDonald criteriaA Canadian expert commentaryDaniel Selchen, Virender Bhan, Gregg Blevins et al.Neurology, December 03, 2012 -
Article
Disruption of neurite morphology parallels MS progressionBarbara Spanò, Giovanni Giulietti, Valerio Pisani et al.Neurology: Neuroimmunology & Neuroinflammation, September 26, 2018